CERS Cerus Corp

$2.58 -1.34%

Updated 16 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

Cerus Corp (CERS) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $519 million. Shares last traded at $2.58, 25.7% below their 52-week high. Over the past year the stock is up 95.1%. Net profit margin is -2.9%, above the peer median of -9.3%. Revenue grew 16.1% year over year.

Market Cap

$519M

Shares Out

201.5M

EPS (TTM)

$-0.17

P/E Ratio

—

P/S Ratio

2.22

P/B Ratio

7.41

Dividend / Share

—

Dividend Yield

—

52-Week High

$3.46

52-Week Low

$1.17

Volume

59,888

Avg Vol (3m)

179,384.286

Performance

-4.63%

+13.94%

-7.54%

+26.85%

YTD

+30.38%

+95.08%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

42.68

SMA (50)

$2.83

SMA (200)

$2.36

Price vs SMA50

-8.85%

Price vs SMA200

+8.96%

ATR (14)

$0.14

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$234M

Net Income

$-7M

Gross Margin

7.2%

Operating Margin

-0.7%

Net Margin

-2.9%

Return on Equity

-9.7%

Return on Assets

-3.3%

Current Ratio

1.83

Debt / Equity

0.29

Revenue Growth (YoY)

+16.1%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.02	2026-07-30
Q1 2026	$-0.01	2026-04-30
FY 2025	$-0.08	2026-03-02
Q3 2025	$-0.07	2025-11-06
Q2 2026	$-0.07	2026-07-30
Q1 2026	$-0.04	2026-04-30

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

CERS vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 16 d ago

P/S vs peers

2.22 / 2.94 med

-24% discount

Net margin vs peers

-2.9% / -9.3% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.